Molecular drivers of lobular carcinoma in situ-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Molecular drivers of lobular carcinoma in situ

Published:2015-06-04 Issue:1 Volume:17 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Logan Greg J.,Dabbs David J.,Lucas Peter C.,Jankowitz Rachel C.,Brown Daniel D.,Clark Beth Z.,Oesterreich Steffi,McAuliffe Priscilla F.

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-015-0580-5.pdf

Reference101 articles.

1. Degnim AC, King TA. Surgical management of high-risk breast lesions. Surg Clin North Am. 2013;93:329–40.

2. Li CI, Daling JR, Malone KE. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev. 2005;14:1008–11.

3. Page DL, Kidd Jr TE, Dupont WD, Simpson JF, Rogers LW. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol. 1991;22:1232–9.

4. Bodian CA, Perzin KH, Lattes R. Lobular neoplasia. Long term risk of breast cancer and relation to other factors. Cancer. 1996;78:1024–34.

5. To T, Wall C, Baines CJ, Miller AB. Is carcinoma in situ a precursor lesion of invasive breast cancer? Int J Cancer. 2014;135:1646–52.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring SALL4 as a significant prognostic marker in breast cancer and its association with progression pathways involved in cancer genesis;Computational Biology and Chemistry;2024-10

2. Is There a Special Role for Ovarian Hormones in the Pathogenesis of Lobular Carcinoma?;Endocrinology;2024-03-29

3. Cancer reduction in mice with Prakasine nanomedicine immunotherapy;Artificial Cells, Nanomedicine, and Biotechnology;2023-10-26

4. DCIS and LCIS: Are the Risk Factors for Developing In Situ Breast Cancer Different?;Cancers;2023-09-02

5. Diagnostic Pitfalls in Breast Cancer Pathology With an Emphasis on Core Needle Biopsy Specimens;Archives of Pathology & Laboratory Medicine;2023-08-31

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3